Oral Cefixime vs Intravenous Piperacillin/Tazobactam and Amikacin in Children with Low Risk Febrile Neutropenia
Phase 3
- Conditions
- Health Condition 1: D703- Neutropenia due to infection
- Registration Number
- CTRI/2023/12/060806
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Those fulfilling the criteria for Low-risk Febrile Neutropenia (defined as minimally myelosuppressive chemotherapy, briefly myelosuppressive chemotherapy ,no clinical focus of infection ,no organ dysfunction , no hemodynamic instability, oral mucositis <grade 3, no profound neutropenia)
Exclusion Criteria
Those who did not consent for oral antibiotics and those who have received oral or intravenous antibiotics in the past 7 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method